Predictive Markers of the Course of Covid-19 Based on Biomarker Serum Amyloid A (SAA) and Genetic Markers

NAActive, not recruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

February 10, 2021

Primary Completion Date

June 26, 2023

Study Completion Date

December 31, 2026

Conditions
COVID-19
Interventions
DIAGNOSTIC_TEST

Nasal swab to collect material for RT-PCR SAA evaluation

Nasal swab for parallel identification of SARS-Cov2 and SAA expression

Trial Locations (1)

Unknown

Thomayer University Hospital, Department of Respiratory Medicine, Prague

All Listed Sponsors
collaborator

Charles University, Czech Republic

OTHER

lead

Thomayer University Hospital

OTHER